Anyone focused on longevity and anti-aging is no stranger to NAD+, known as the "energy currency" within cells. It is involved in nearly all vital life processes, from energy metabolism to DNA repair and immune regulation.
NAD+ levels in the human body naturally decline with age, a process closely linked to multiple chronic diseases and aging. To replenish NAD+, scientists have identified several "precursor substances" — raw materials that can be converted into NAD+ once inside the body.
The three most common NAD+ precursor supplements on the market are nicotinamide (Nam), nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN), all of which are derivatives of vitamin B3. These products are often marketed with claims of "anti-aging" and "energy boosting", but what sets them apart from one another?
Recently, a groundbreaking study published in Nature Metabolism[1] directly compared the effects of these three precursors in healthy human subjects for the first time. The results are clear: NR and NMN deliver comparable performance, while Nam falls significantly short.
NAD+: The Indispensable "Currency" of Life
Before comparing the three precursors, we first need to understand their target: NAD+.
Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme present in all living cells. No life process can function without it — without NAD+, critical cellular processes including cellular respiration, adenosine triphosphate (ATP) energy production, DNA repair (via activation of PARP enzymes), and gene expression regulation (via effects on sirtuin longevity proteins) would come to a complete halt.
Studies have shown that declining NAD+ levels are associated with metabolic syndrome, neurodegenerative diseases, cardiovascular disease, and even the aging process itself. For this reason, boosting NAD+ levels via precursor supplementation is regarded as a promising health intervention strategy.
In recent years, NR and NMN, as vitamin B3 derivatives, have entered the public eye. NR is a naturally occurring nucleoside with overlapping functions with Nam, while NMN is the phosphorylated form of NR.
Study Revealed: A Fair Head-to-Head Competition
This study, led by the University of Amsterdam Medical Center in the Netherlands, was a randomized, placebo-controlled, four-parallel-arm clinical trial[1]. It enrolled 65 healthy adults aged 18-50, who were randomly assigned to four groups:
- Nicotinamide (Nam) group: 500 mg (4.1 mmol) daily
- Nicotinamide Riboside (NR) group: 1000 mg (3.4 mmol) daily
- Nicotinamide Mononucleotide (NMN) group: 1000 mg (3 mmol) daily
- Placebo group
All subjects took the assigned dose once daily for 14 consecutive days, and underwent detailed metabolic testing on Day 1 and Day 14, including assessment of acute response within 4 hours after dosing and chronic effects after 14 days of supplementation. Researchers used liquid chromatography-tandem mass spectrometry to accurately measure concentration changes of NAD+ and its related metabolites in whole blood, plasma, and urine.
Chronic Effects: NR and NMN Neck and Neck, Nam Unexpectedly Underperforms
The study results first overturned the traditional perception of these three precursors. After 14 consecutive days of supplementation:
- NR and NMN both approximately doubled whole blood NAD+ concentrations, increasing by 49.4 μM and 43.1 μM respectively. The effects were significant, with no statistical difference between the two.
- In contrast, Nam failed to increase basal NAD+ levels.
This indicates that although Nam is the earliest used form of vitamin B3, its efficacy in boosting NAD+ in healthy adults is far inferior to that of NR and NMN.
Acute Effects: Nam's Rapid Response — Fast Onset, Fast Decline
In terms of acute effects, the three precursors showed completely different characteristics. Nam was rapidly absorbed within 1 hour after oral administration, with whole blood Nam concentrations soaring and NAD+ levels rising transiently. However, this effect was "fast onset, fast decline", accompanied by the production of large amounts of degradation products such as N1-methylnicotinamide (MeNam), indicating that Nam was rapidly metabolized and excreted.
In contrast, NR and NMN showed no acute effect within the 4-hour observation window.
Gut Microbiota: The Hidden Driver Behind NAD+ Boosting
Why do NR and NMN take time to take effect, while Nam acts quickly?
In vitro fermentation experiments revealed the key mechanism: gut microbiota is the core link for the effects of NR and NMN. Researchers co-cultured fecal microbiota from healthy humans with NR/NMN or Nam for 48 hours, and the results showed that:
Human gut microbiota can convert NR and NMN into Nam, and further deamidate it into nicotinic acid (NA). This deamidation step relies on the bacterial enzyme PncA. The produced NA is then absorbed by the human body and efficiently synthesized into NAD+ through the Preiss-Handler Pathway in tissues such as the liver.
In contrast, Nam was inefficiently converted to NA by the microbiota in the experiments. This suggests that oral Nam is likely directly absorbed into the bloodstream in the proximal small intestine, and then rapidly converted to NAD+ mainly through the hepatic Salvage Synthesis Pathway, explaining its rapid but transient effect.
Beyond NAD+ Boosting: Potential Gut Health Benefits
The study also pointed out a potential additional benefit of NR and NMN: the regulation of gut microbiota function.
While promoting the production of NA by the microbiota, NR and NMN also increased the production of total short-chain fatty acids (SCFAs). SCFAs are a key marker of gut health, with multiple benefits including anti-inflammatory effects, maintenance of intestinal barrier integrity, and immune regulation.
This promotion of microbiota metabolism was observed in fecal samples from healthy adults, the elderly, and patients with Crohn's disease, showing a certain degree of universality.
Therefore, NR and NMN supplementation may deliver a "two-for-one" effect: both long-term systemic NAD+ elevation, and potential gut health benefits through improved microbiota metabolism.
Conclusion and Outlook
This groundbreaking study is the first to systematically elucidate the metabolic differences between the three major NAD+ precursors in humans, bringing gut microbiota to the center stage of NAD+ supplementation. It tells us that NAD+ boosting is not a simple "you are what you eat" process, but the result of precise collaboration between the host and microbiota.
As highlighted in a companion commentary, future research should focus on "how to optimize the bioavailability of NAD+ supplements" and "how to identify specific populations that can truly benefit from NAD+ elevation"[2]. Perhaps in the near future, personalized NAD+ supplementation regimens based on individual gut microbiota characteristics will become a reality, opening up new avenues for anti-aging and disease prevention.
Scientific data shows that even different crystalline salt forms of NAD+ precursors can lead to significant differences in in vivo efficacy. Max Scientific, the developer of Revitality, the founder of the NAD+ market, has announced the launch of Revitality G5, based on a new proprietary NAD+ precursor. Data shows that the NAD+ boosting efficiency of this precursor can reach more than 3 times that of NMN.
References
[1] Christen, S. et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism (2026). doi:10.1038/s42255-025-01421-8
[2] The microbiome at the centre of NAD+ supplementation. PubMed.